Leadership Team

Mark Mayhew

Corporate Development Leader
McKinsey Strategy Consultant
PhD in Biochemistry
Treehill Partners

Focused on Transactions and Transitions in Healthcare

Diverse senior team with complementary backgrounds from banking & finance, strategic consulting, and leadership roles in industry. In-house medical, scientific, product development and commercialization expertise

Dr Mark Mayhew is Head of Portfolio and Strategy at Treehill Partners. He is an experienced corporate development executive and strategy advisor with significant expertise across development and commercial stage pharmaceuticals, transcending the disciplines of strategic corporate development, asset development, and corporate finance.

At Treehill, Mark’s work is focused on the identification and deep evaluation of optimal transaction solutions based on asset, portfolio and strategic fundamentals. He excels combining strong strategic vision, a profound understanding of value creation process in both therapeutics R&D as well as commercialization, and a straight-forward approach to addressing business needs.

Mark’s experience includes over two decades in the bio-pharmaceutical industry, initially with McKinsey and Company (New York) from where he joined Esteve Pharmaceuticals (Barcelona) as Head of Corporate and Business Development.

Prior to his industry career, Mark spent almost a decade as a research scientist, both in Academia and Biotechnology, including as Chief Scientist of an academic spin-out pharmaceutical venture.

Mark holds a PhD and a bachelor’s degree in biochemistry from Oxford University, UK.